Jeannett W. Jackman

Jeannett W. Jackman serves as a Contract Specialist responsible for managing the full lifecycle of procurement actions within a federal entity focused on biological product manufacturing. She ensures compliance with federal acquisition regulations, conducts market research, develops solicitation documents, and administers contracts to secure critical biopharmaceutical inputs and related manufacturing services. Her role is central to advancing the agency’s mission of acquiring safe, effective, and scientifically validated biological products, often requiring specialized technical oversight and stringent regulatory alignment with FDA standards. Jackman collaborates with a network of qualified vendors specializing in biologics production, including contract development and manufacturing organizations (CDMOs) and GMP-certified facilities. While no single contractor dominates her portfolio, she maintains consistent engagement with firms possessing validated manufacturing capabilities, sterile processing expertise, and established quality systems. Her working relationships are characterized by a focus on technical competence, regulatory compliance, and performance reliability, with an emphasis on long-term contract execution over transactional engagements. Her procurement patterns reflect a strong preference for open competition, with 100% of her acquisitions conducted without set-aside designations. This indicates a strategic focus on sourcing from the broadest possible pool of qualified offerors, prioritizing technical capability and regulatory readiness over socioeconomic categorizations. While she does not routinely utilize 8(a), HUBZone, or SDVOSB set-asides, her approach ensures rigorous evaluation of all bidders based on merit and compliance with technical specifications. Jackman’s primary procurement focus is on NAICS 325414—Biological Product (except Diagnostic) Manufacturing—encompassing the acquisition of therapeutic biologics, vaccines, cell and gene therapies, and associated manufacturing services. She possesses deep domain expertise in cGMP environments, cold chain logistics, and biologics stability requirements, ensuring that all procurements meet stringent federal standards for safety, purity, and potency. Her work supports mission-critical public health initiatives through scientifically sound and compliant sourcing.